Switch theme
Sign up to access all valuation multiples
Shanghai Junshi Biosciences Co Ltd is a China-based biotechnology companyy with all-round capabilities in innovative drug discovery and development, clinical research on a global scale, large-scale production capacity to commercialization on the full industry chain. Aiming to develop first-in-class or bestin-class drugs by way of original innovation and co-development. Companies operations are located in the PRC and the USA.
2012
2.6K+
LTM Revenue $325M
LTM EBITDA -$131M
$3.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Shanghai Junshi has a last 12-month revenue of $325M and a last 12-month EBITDA of -$131M.
In the most recent fiscal year, Shanghai Junshi achieved revenue of $193M and an EBITDA of -$277M.
Shanghai Junshi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Shanghai Junshi valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $187M | $193M | XXX | XXX | XXX |
| Gross Profit | $356M | $119M | XXX | XXX | XXX |
| Gross Margin | 190% | 62% | XXX | XXX | XXX |
| EBITDA | -$302M | -$277M | XXX | XXX | XXX |
| EBITDA Margin | -162% | -144% | XXX | XXX | XXX |
| Net Profit | -$92.4M | -$307M | XXX | XXX | XXX |
| Net Margin | -49% | -159% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Shanghai Junshi's stock price is HKD 29 (or $4).
Shanghai Junshi has current market cap of HKD 28.2B (or $3.6B), and EV of HKD 28.2B (or $3.6B).
See Shanghai Junshi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.6B | $3.6B | XXX | XXX | XXX | XXX | $-0.15 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Shanghai Junshi has market cap of $3.6B and EV of $3.6B.
Shanghai Junshi's trades at 11.9x LTM EV/Revenue multiple, and -29.6x LTM EBITDA.
Analysts estimate Shanghai Junshi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Shanghai Junshi and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.6B | XXX | XXX | XXX |
| EV/Revenue | 18.8x | XXX | XXX | XXX |
| EV/EBITDA | -13.1x | XXX | XXX | XXX |
| P/E | -12.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -9.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpShanghai Junshi's NTM/LTM revenue growth is 41%
Shanghai Junshi's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Shanghai Junshi's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Shanghai Junshi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Shanghai Junshi and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -144% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -8% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -103% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 56% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 129% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 219% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shanghai Junshi acquired XXX companies to date.
Last acquisition by Shanghai Junshi was XXXXXXXX, XXXXX XXXXX XXXXXX . Shanghai Junshi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Shanghai Junshi founded? | Shanghai Junshi was founded in 2012. |
| Where is Shanghai Junshi headquartered? | Shanghai Junshi is headquartered in Hong Kong. |
| How many employees does Shanghai Junshi have? | As of today, Shanghai Junshi has 2.6K+ employees. |
| Who is the CEO of Shanghai Junshi? | Shanghai Junshi's CEO is Mr. Cong Li. |
| Is Shanghai Junshi publicy listed? | Yes, Shanghai Junshi is a public company listed on HKG. |
| What is the stock symbol of Shanghai Junshi? | Shanghai Junshi trades under 01877 ticker. |
| When did Shanghai Junshi go public? | Shanghai Junshi went public in 2018. |
| Who are competitors of Shanghai Junshi? | Similar companies to Shanghai Junshi include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Shanghai Junshi? | Shanghai Junshi's current market cap is $3.6B |
| What is the current revenue of Shanghai Junshi? | Shanghai Junshi's last 12-month revenue is $325M. |
| What is the current EBITDA of Shanghai Junshi? | Shanghai Junshi's last 12-month EBITDA is -$131M. |
| What is the current EV/Revenue multiple of Shanghai Junshi? | Current revenue multiple of Shanghai Junshi is 11.9x. |
| What is the current EV/EBITDA multiple of Shanghai Junshi? | Current EBITDA multiple of Shanghai Junshi is -29.6x. |
| What is the current revenue growth of Shanghai Junshi? | Shanghai Junshi revenue growth between 2023 and 2024 was 3%. |
| Is Shanghai Junshi profitable? | Yes, Shanghai Junshi is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
